Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prognostic Stage IIIA Breast Cancer AJCC v8”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00063934
What this trial is testing

Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Male Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer+2 more
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Looking for participantsNCT07016399
What this trial is testing

Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Triple-Negative Breast Carcinoma
Vandana Abramson 51
Not applicableEnded earlyNCT03751449
What this trial is testing

Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+21 more
Roswell Park Cancer Institute 10
Not applicableUnknownNCT00436709
What this trial is testing

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 75
Not applicableWithdrawnNCT01558778
What this trial is testing

Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more
Roswell Park Cancer Institute
Not applicableStudy completedNCT00769821
What this trial is testing

The Impact of Lymphedema on Breast Cancer Survivors

Who this might be right for
Breast CancerCancer SurvivorLymphedema+1 more
University of California, San Francisco 145
Early research (Phase 1)Study completedNCT00008034
What this trial is testing

Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 15
Early research (Phase 1)Ended earlyNCT04185311
What this trial is testing

Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+19 more
Jonsson Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT01234532
What this trial is testing

Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerProgesterone Receptor-negative Breast Cancer+4 more
University of Maryland, Baltimore 5
Not applicableStudy completedNCT01219075
What this trial is testing

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

Who this might be right for
BRCA1 Mutation CarrierBRCA2 Mutation CarrierDuctal Breast Carcinoma in Situ+6 more
University of Southern California 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT02315196
What this trial is testing

Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerProgesterone Receptor-negative Breast Cancer+6 more
Rutgers, The State University of New Jersey 62
Not applicableStudy completedNCT00082654
What this trial is testing

Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00462410
What this trial is testing

Effect of Advertisements on Treatment Compliance in Women With Breast Cancer

Who this might be right for
Breast Cancer
Institut Bergonié 65
Not applicableStudy completedNCT00462696
What this trial is testing

MRI in Evaluating Early Response to Chemotherapy in Women With Infiltrating Breast Cancer

Who this might be right for
Breast Cancer
Institut Bergonié 16
Testing effectiveness (Phase 2)Study completedNCT00978770
What this trial is testing

MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Cancer Clinical Trials Unit, Scotland 50
Testing effectiveness (Phase 2)Study completedNCT00943410
What this trial is testing

Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 19
Large-scale testing (Phase 3)Study completedNCT00893061
What this trial is testing

Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Centre Oscar Lambret 44
Not applicableEnded earlyNCT00503841
What this trial is testing

Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 44
Testing effectiveness (Phase 2)Study completedNCT00003125
What this trial is testing

Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors

Who this might be right for
Breast CancerEsophageal CancerGastric Cancer+3 more
Georgetown University 24
Not applicableUnknownNCT00897728
What this trial is testing

Study of Tumor and Blood Samples From Women With Breast Cancer

Who this might be right for
Breast Cancer
Institut Curie 180
Next Page